Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. More Details
Flawless balance sheet and fair value.
Share Price & News
How has Henry Schein's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HSIC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: HSIC's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: HSIC underperformed the US Healthcare industry which returned 35.3% over the past year.
Return vs Market: HSIC underperformed the US Market which returned 39.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Henry Schein's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StIs Henry Schein, Inc.'s (NASDAQ:HSIC) Recent Stock Performance Influenced By Its Financials In Any Way?
3 weeks ago | Simply Wall StIs Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?
1 month ago | Simply Wall StAn Intrinsic Calculation For Henry Schein, Inc. (NASDAQ:HSIC) Suggests It's 35% Undervalued
Is Henry Schein undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: HSIC ($77.36) is trading below our estimate of fair value ($121.55)
Significantly Below Fair Value: HSIC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: HSIC is poor value based on its PE Ratio (25.1x) compared to the US Healthcare industry average (21.1x).
PE vs Market: HSIC is poor value based on its PE Ratio (25.1x) compared to the US market (18.4x).
Price to Earnings Growth Ratio
PEG Ratio: HSIC is poor value based on its PEG Ratio (2.3x)
Price to Book Ratio
PB vs Industry: HSIC is good value based on its PB Ratio (3.3x) compared to the US Healthcare industry average (3.9x).
How is Henry Schein forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HSIC's forecast earnings growth (11.2% per year) is above the savings rate (2%).
Earnings vs Market: HSIC's earnings (11.2% per year) are forecast to grow slower than the US market (15.1% per year).
High Growth Earnings: HSIC's earnings are forecast to grow, but not significantly.
Revenue vs Market: HSIC's revenue (2.5% per year) is forecast to grow slower than the US market (9.3% per year).
High Growth Revenue: HSIC's revenue (2.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HSIC's Return on Equity is forecast to be low in 3 years time (12.9%).
How has Henry Schein performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HSIC has high quality earnings.
Growing Profit Margin: HSIC's current net profit margins (4.1%) are lower than last year (7.1%).
Past Earnings Growth Analysis
Earnings Trend: HSIC's earnings have grown by 2.4% per year over the past 5 years.
Accelerating Growth: HSIC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HSIC had negative earnings growth (-38.5%) over the past year, making it difficult to compare to the Healthcare industry average (58.4%).
Return on Equity
High ROE: HSIC's Return on Equity (10.3%) is considered low.
How is Henry Schein's financial position?
Financial Position Analysis
Short Term Liabilities: HSIC's short term assets ($3.6B) exceed its short term liabilities ($2.1B).
Long Term Liabilities: HSIC's short term assets ($3.6B) exceed its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: HSIC's debt to equity ratio (15.3%) is considered satisfactory.
Reducing Debt: HSIC's debt to equity ratio has reduced from 32% to 15.3% over the past 5 years.
Debt Coverage: HSIC's debt is well covered by operating cash flow (85.9%).
Interest Coverage: HSIC's interest payments on its debt are well covered by EBIT (19x coverage).
What is Henry Schein current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HSIC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HSIC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HSIC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HSIC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HSIC's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Stanley Bergman (71 yo)
Mr. Stanley M. Bergman has been the Chief Executive Officer and Executive Chairman of Henry Schein, Inc. since 1989 and has been its Executive Director since 1982. Mr. Bergman served as the President of He...
CEO Compensation Analysis
Compensation vs Market: Stanley's total compensation ($USD7.79M) is below average for companies of similar size in the US market ($USD11.26M).
Compensation vs Earnings: Stanley's compensation has been consistent with company performance over the past year.
Experienced Management: HSIC's management team is seasoned and experienced (9.5 years average tenure).
Experienced Board: HSIC's board of directors are seasoned and experienced ( 15 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: HSIC insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Henry Schein, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Henry Schein, Inc.
- Ticker: HSIC
- Exchange: NasdaqGS
- Founded: 1932
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$10.884b
- Shares outstanding: 140.70m
- Website: https://www.henryschein.com
Number of Employees
- Henry Schein, Inc.
- 135 Duryea Road
- New York
- United States
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/25 22:39|
|End of Day Share Price||2021/07/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.